β³ Fetching live dividend data...
Home βΊ Calculator βΊ ACUR Dividend Calculator 2026
Acura Pharmaceuticals, Inc. Β· OTC
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ACUR β $3.603059672953261e+54M in 10 years Β· $300,254,958,085,218,450,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to exploring, developing, and bringing to market novel technologies and products aimed at enhancing medication safety across the United States. Its product portfolio features Oxaydo tablets, a potent Schedule II narcotic prescribed for managing both acute and chronic moderate-to-severe pain. The company also offers the Nexafed line, consisting of pseudoephedrine and acetaminophen tablets, widely utilized as nasal decongestants in a range of over-the-counter and prescription formulations for cold, sinus, and allergy relief. Beyond its current offerings, Acura is actively advancing six additional opioid products through various stages of formulation development. To support its global reach, Acura Pharmaceuticals maintains strategic collaboration and licensing agreements with Egalet US, Inc. and Egalet Ltd. for the worldwide production and commercialization of its Oxaydo products. Furthermore, it has established a development and commercialization partnership with Abuse Deterrent Pharma, LLC to create LTX-03, an immediate-release tablet leveraging the proprietary LIMITx technology. Established in 1935, the company's operations are headquartered in Palatine, Illinois.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open ACUR position with:
Real after-tax yield depends on where you live and how you hold ACUR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 1600000.00% | 1599997.20% | $160,000,000 / yr |
| π¬π§ UK ISA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| π¬π§ UK Taxable | 8.75% | 1825000.00% | 1824997.20% | $182,500,000 / yr |
| π¨π¦ TFSA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| π¨π¦ CA Taxable | 25% | 1500000.00% | 1499997.20% | $150,000,000 / yr |
| π¦πΊ Super (pension) | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| π¦πΊ AU Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
| π©πͺ DE Taxable | 26.375% | 1472500.00% | 1472497.20% | $147,250,000 / yr |
| π«π· FR Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
ACUR pays quarterly β 4 times per year. Next ex-div: TBD.
How ACUR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ACUR sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-01-02 | 50,000 | $0.01 | $500.00 | ||
| A-Award | 2026-01-02 | 50,000 | β | β | ||
| M-Exempt | 2026-01-02 | 50,000 | β | β | ||
| M-Exempt | 2026-01-02 | 50,000 | $0.01 | $500.00 | ||
| A-Award | 2026-01-02 | 50,000 | β | β | ||
| M-Exempt | 2026-01-02 | 50,000 | β | β | ||
| M-Exempt | 2026-01-02 | 50,000 | $0.01 | $500.00 | ||
| A-Award | 2026-01-02 | 50,000 | β | β | ||
| M-Exempt | 2026-01-02 | 50,000 | β | β | ||
| M-Exempt | 2025-01-02 | 50,000 | $0.01 | $500.00 |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ACUR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Acura Pharmaceuticals, Inc. (ACUR) is currently trading at $0.00, trading near its 52-week low. The current dividend yield is 2000000.00% based on an annual payout of $2.00 per share.
Acura Pharmaceuticals, Inc. (ACUR) is a healthcare stock currently trading at $0.00 with a dividend yield of 2000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever